RHYTHM PHARMACEUTICALS INC (RYTM)
US76243J1051 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to RYTM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 60.07. This target is 44.98% above the current price.
RYTM was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about RYTM.
In the previous month the buy percentage consensus was at a similar level.
RYTM was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-26 | Needham | Reiterate | Buy -> Buy |
| 2024-04-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-02-22 | Needham | Reiterate | Buy -> Buy |
| 2024-01-26 | Needham | Reiterate | Buy -> Buy |
| 2024-01-26 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-01-04 | Needham | Maintains | Buy -> Buy |
| 2023-12-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-12-19 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-12-07 | Needham | Maintains | Buy -> Buy |
| 2023-12-07 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-11-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-02 | Needham | Reiterate | Buy -> Buy |
| 2023-08-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-08-02 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | Needham | Reiterate | Buy -> Buy |
| 2023-04-18 | Needham | Reiterate | Buy |
| 2023-03-02 | Ladenburg Thalmann | Reiterate | Buy |
| 2023-03-02 | Needham | Reiterate | Buy |
| 2023-03-02 | Canaccord Genuity | Maintains | Buy |
| 2023-03-02 | Goldman Sachs | Maintains | Buy |
| 2023-03-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-26 | Goldman Sachs | Maintains | Buy |
| 2022-11-10 | Goldman Sachs | Maintains | Buy |
| 2022-11-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-08 | Goldman Sachs | Maintains | Buy |
| 2022-08-08 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2022-08-05 | B of A Securities | Upgrade | Underperform -> Neutral |